Immunomedics Inc
(IMMU)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2012 | 09-2012 | 06-2012 | 03-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -12,357 | -7,167 | N/A | 8,242 | 15,540 |
| Depreciation Amortization | 528 | 264 | N/A | 1,246 | 852 |
| Other Working Capital | -573 | -821 | N/A | -31 | 820 |
| Other Operating Activity | 1,059 | 335 | 0 | 1,551 | -27,381 |
| Operating Cash Flow | $-11,343 | $-7,388 | $N/A | $11,008 | $-10,169 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -194 | -98 | N/A | -378 | -302 |
| Other Investing Activity | 138 | 138 | 0 | 0 | 0 |
| Investing Cash Flow | $-56 | $40 | $N/A | $-378 | $-302 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 61 | 59 | N/A | 1,597 | 15 |
| Common Stock Repurchased | -39 | N/A | N/A | 0 | -50 |
| Other Financing Activity | -173 | -138 | 0 | -76 | 0 |
| Financing Cash Flow | $-151 | $-79 | $N/A | $1,522 | $-34 |
| Exchange Rate Effect | 112 | 109 | N/A | -198 | -258 |
| Beginning Cash Position | 32,838 | 32,838 | N/A | 27,098 | 27,098 |
| End Cash Position | 21,400 | 25,520 | N/A | 39,051 | 16,334 |
| Net Cash Flow | $-11,438 | $-7,318 | $N/A | $11,953 | $-10,763 |
| Free Cash Flow | |||||
| Operating Cash Flow | -11,343 | -7,388 | N/A | 11,008 | -10,169 |
| Capital Expenditure | -194 | -98 | N/A | -378 | -302 |
| Free Cash Flow | -11,537 | -7,486 | 0 | 10,630 | -10,471 |